Deep Vein Thrombosis Treatments

Clot-Busting Tools

Percutaneous mechanical thrombectomy (PMT) devices are increasingly being used to remove clots from coronary and peripheral vessels. They offer a faster treatment option than using traditional systemic thrombolytic (lytic) or catheter-directed thr...

Bayer AngioJet DVT
Catheter-Based Clot Busting Therapies
Catheter-based thrombectomy systems are increasingly being used to remove blood clots from vessels inside the body, often as an adjunct therapy to systemic...
DVT Clots Quickly, Safely Removed With Pharmacomechanical...
Bathing dangerous blood clots in special medication, breaking them up with jets of saline and vacuuming them out of the body is a fast, effective method of...
Stryker Launches Next Generation Trevo ProVue Retrieval...
Stryker announced the global commercial launch of the new Trevo ProVue Retriever. The Trevo ProVue Retriever is the first clot removal device fully visible...
Xarelto rivaroxaban Janssen Pharmaceuticals Deep Vein Thromosis Treament
FDA Clears Rivaroxaban to Treat Deep Vein Thrombosis,...
Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved rivaroxaban (Xarelto), an oral anticoagulant, for the treatment...
Trevo ProVue Retriever Allows Physicians to Visualize Placement, Clot Interaction and Retrieval
The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise positioning within the clot and
Rivaroxaban for Treatment of Deep Vein Thrombosis, Pulmonary Embolism
Rivaroxaban (Xarelto) is an oral anticoagulant for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and to...
Next-Generation Aspiration Catheter Features Improved Visibility
The Fetch 2 Catheter, by Medrad Interventional, features a flexible, variable pitch coiled shaft for improved kink resistance. Other...
Generic Deep Vein Thrombosis Drug Cleared by FDA
The first generic version of Lovenox (enoxaparin sodium injection), an anticoagulant drug used for multiple indications, including...
View All »

Articles

Bayer AngioJet DVT
Catheter-Based Clot Busting Therapies
Catheter-based thrombectomy systems are increasingly being used to remove blood clots from vessels inside the body, often as an adjunct therapy to systemic...
Clot-Busting Tools
Percutaneous mechanical thrombectomy (PMT) devices are increasingly being used to remove clots from coronary and peripheral vessels. They offer a faster...
Venous Imaging Key to Thwarting Killer Clots
A clot that forms in the deep vein in either the leg or pelvic region is known as a deep vein thrombosis (DVT), an increasingly common venous disease, which...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
10 weeks 5 days ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 19 hours ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
18 weeks 6 days ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available